Atlas Trials

PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of Ceftriaxone

Clinical trial NCT02265406 · COMPLETED

Trial details

NCT number
NCT02265406
Sponsor
Poitiers University Hospital
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Early Ventilation Acquired Pneumonia in Brain Injured Patients
Start date
2015-10-01
Primary completion
2020-07-25
Enrollment
354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.